> Merck's subsidiary in India launched its diabetes drug Januvia at one-fifth the U.S. price, establishing a strategy of high-volume, low-margin sales for that market, local executives said. Report ...
(Reuters) - Details of a large heart safety study presented on Monday appear to give Merck and Co's diabetes drug Januvia a clean bill of health, possibly setting the stage for a return to sales ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback